We are pleased to announce that InVivo BioTech Services GmbH will be exhibiting at the 12th Immunotherapy of Cancer Conference (iTOC12), taking place March 12–14, 2026 in Munich. iTOC12 is a leading European meeting that provides a global platform for translational research in immuno‑oncology, enabling exchange on the latest findings and the challenges of early clinical translation.
At InVivo BioTech, we support scientists and research organizations with our expertise in custom antibody development, recombinant protein expression, and high‑quality assay support. Our tailored workflows and long‑standing experience help accelerate projects in immuno‑oncology and biomarker research.
Visit us at Booth 9 to learn how our solutions can strengthen your research programs.
Don’t miss our company pitch!
Join us on March 12 at 14:50 for a 10‑minute presentation showcasing our capabilities and how we collaborate with research teams to drive scientific progress.
We look forward to meeting you in Munich and exchanging ideas at this dynamic forum dedicated to advancing cancer immunotherapy.